nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0197	0.0263	CbGbCtD
Fluvoxamine—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0185	0.0248	CbGbCtD
Fluvoxamine—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0185	0.0248	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0175	0.0235	CbGbCtD
Fluvoxamine—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0175	0.0235	CbGbCtD
Fluvoxamine—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0167	0.0224	CbGbCtD
Fluvoxamine—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0151	0.0203	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0151	0.0203	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0147	0.0197	CbGbCtD
Fluvoxamine—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0147	0.0197	CbGbCtD
Fluvoxamine—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0146	0.0195	CbGbCtD
Fluvoxamine—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.014	0.0188	CbGbCtD
Fluvoxamine—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0133	0.0178	CbGbCtD
Fluvoxamine—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0133	0.0178	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0133	0.0178	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0133	0.0178	CbGbCtD
Fluvoxamine—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0132	0.0176	CbGbCtD
Fluvoxamine—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0132	0.0176	CbGbCtD
Fluvoxamine—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0128	0.0172	CbGbCtD
Fluvoxamine—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0127	0.017	CbGbCtD
Fluvoxamine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0125	0.0167	CbGbCtD
Fluvoxamine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0117	0.0157	CbGbCtD
Fluvoxamine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0115	0.0154	CbGbCtD
Fluvoxamine—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0114	0.0152	CbGbCtD
Fluvoxamine—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.011	0.0148	CbGbCtD
Fluvoxamine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0108	0.0145	CbGbCtD
Fluvoxamine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0108	0.0145	CbGbCtD
Fluvoxamine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0106	0.0142	CbGbCtD
Fluvoxamine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0106	0.0142	CbGbCtD
Fluvoxamine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0104	0.0139	CbGbCtD
Fluvoxamine—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00998	0.0134	CbGbCtD
Fluvoxamine—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00998	0.0134	CbGbCtD
Fluvoxamine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0098	0.0131	CbGbCtD
Fluvoxamine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00976	0.0131	CbGbCtD
Fluvoxamine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00976	0.0131	CbGbCtD
Fluvoxamine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00949	0.0127	CbGbCtD
Fluvoxamine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00947	0.0127	CbGbCtD
Fluvoxamine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00917	0.0123	CbGbCtD
Fluvoxamine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00893	0.012	CbGbCtD
Fluvoxamine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00893	0.012	CbGbCtD
Fluvoxamine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0089	0.0119	CbGbCtD
Fluvoxamine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00883	0.0118	CbGbCtD
Fluvoxamine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00883	0.0118	CbGbCtD
Fluvoxamine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00857	0.0115	CbGbCtD
Fluvoxamine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00821	0.011	CbGbCtD
Fluvoxamine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00807	0.0108	CbGbCtD
Fluvoxamine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00807	0.0108	CbGbCtD
Fluvoxamine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00805	0.0108	CbGbCtD
Fluvoxamine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00805	0.0108	CbGbCtD
Fluvoxamine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00772	0.0103	CbGbCtD
Fluvoxamine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00762	0.0102	CbGbCtD
Fluvoxamine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00743	0.00995	CbGbCtD
Fluvoxamine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0074	0.00991	CbGbCtD
Fluvoxamine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0074	0.00991	CbGbCtD
Fluvoxamine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00718	0.00962	CbGbCtD
Fluvoxamine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00697	0.00934	CbGbCtD
Fluvoxamine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00677	0.00906	CbGbCtD
Fluvoxamine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00669	0.00896	CbGbCtD
Fluvoxamine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00669	0.00896	CbGbCtD
Fluvoxamine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00649	0.0087	CbGbCtD
Fluvoxamine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00649	0.0087	CbGbCtD
Fluvoxamine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00641	0.00859	CbGbCtD
Fluvoxamine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00623	0.00834	CbGbCtD
Fluvoxamine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00612	0.0082	CbGbCtD
Fluvoxamine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00612	0.0082	CbGbCtD
Fluvoxamine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00604	0.00809	CbGbCtD
Fluvoxamine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00568	0.0076	CbGbCtD
Fluvoxamine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00568	0.0076	CbGbCtD
Fluvoxamine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00513	0.00688	CbGbCtD
Fluvoxamine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00513	0.00688	CbGbCtD
Fluvoxamine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00482	0.00645	CbGbCtD
Fluvoxamine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00443	0.00594	CbGbCtD
Fluvoxamine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0043	0.00576	CbGbCtD
Fluvoxamine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00389	0.00521	CbGbCtD
Fluvoxamine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00389	0.00521	CbGbCtD
Fluvoxamine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00373	0.005	CbGbCtD
Fluvoxamine—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00182	0.0571	CbGeAlD
Fluvoxamine—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00126	0.0396	CbGeAlD
Fluvoxamine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00104	0.0328	CbGeAlD
Fluvoxamine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000853	0.0268	CbGeAlD
Fluvoxamine—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000822	0.0258	CbGeAlD
Fluvoxamine—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000817	0.0257	CbGeAlD
Fluvoxamine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000809	0.0254	CbGeAlD
Fluvoxamine—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000767	0.0241	CbGeAlD
Fluvoxamine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000617	0.0194	CbGeAlD
Fluvoxamine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000607	0.0191	CbGeAlD
Fluvoxamine—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.000485	0.0152	CbGeAlD
Fluvoxamine—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000485	0.0152	CbGeAlD
Fluvoxamine—SLC6A4—blood—acquired immunodeficiency syndrome	0.000462	0.0145	CbGeAlD
Fluvoxamine—SIGMAR1—blood—acquired immunodeficiency syndrome	0.000458	0.0144	CbGeAlD
Fluvoxamine—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000445	0.014	CbGeAlD
Fluvoxamine—SIGMAR1—bone marrow—acquired immunodeficiency syndrome	0.000444	0.0139	CbGeAlD
Fluvoxamine—SIGMAR1—spinal cord—acquired immunodeficiency syndrome	0.000442	0.0139	CbGeAlD
Fluvoxamine—SLC6A3—lung—acquired immunodeficiency syndrome	0.000442	0.0139	CbGeAlD
Fluvoxamine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000437	0.0137	CbGeAlD
Fluvoxamine—SIGMAR1—vagina—acquired immunodeficiency syndrome	0.000425	0.0134	CbGeAlD
Fluvoxamine—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.000409	0.0128	CbGeAlD
Fluvoxamine—SLC6A4—lung—acquired immunodeficiency syndrome	0.000405	0.0127	CbGeAlD
Fluvoxamine—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000404	0.0127	CbGeAlD
Fluvoxamine—SIGMAR1—lung—acquired immunodeficiency syndrome	0.000402	0.0126	CbGeAlD
Fluvoxamine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000401	0.0126	CbGeAlD
Fluvoxamine—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.000394	0.0124	CbGeAlD
Fluvoxamine—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000393	0.0123	CbGeAlD
Fluvoxamine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000382	0.012	CbGeAlD
Fluvoxamine—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000375	0.0118	CbGeAlD
Fluvoxamine—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000361	0.0113	CbGeAlD
Fluvoxamine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000355	0.0111	CbGeAlD
Fluvoxamine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000328	0.0103	CbGeAlD
Fluvoxamine—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000323	0.0102	CbGeAlD
Fluvoxamine—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000318	0.01	CbGeAlD
Fluvoxamine—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000316	0.00994	CbGeAlD
Fluvoxamine—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000314	0.00988	CbGeAlD
Fluvoxamine—SLC6A3—brain—acquired immunodeficiency syndrome	0.000313	0.00982	CbGeAlD
Fluvoxamine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000312	0.00982	CbGeAlD
Fluvoxamine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000311	0.00978	CbGeAlD
Fluvoxamine—CYP1A1—blood—acquired immunodeficiency syndrome	0.000308	0.00968	CbGeAlD
Fluvoxamine—CYP3A5—blood—acquired immunodeficiency syndrome	0.000301	0.00947	CbGeAlD
Fluvoxamine—CYP2B6—blood—acquired immunodeficiency syndrome	0.000299	0.00941	CbGeAlD
Fluvoxamine—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000299	0.00938	CbGeAlD
Fluvoxamine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000297	0.00932	CbGeAlD
Fluvoxamine—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000295	0.00927	CbGeAlD
Fluvoxamine—SLC6A4—brain—acquired immunodeficiency syndrome	0.000286	0.009	CbGeAlD
Fluvoxamine—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000286	0.00898	CbGeAlD
Fluvoxamine—SIGMAR1—brain—acquired immunodeficiency syndrome	0.000284	0.00894	CbGeAlD
Fluvoxamine—CYP2E1—blood—acquired immunodeficiency syndrome	0.000281	0.00883	CbGeAlD
Fluvoxamine—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000279	0.00878	CbGeAlD
Fluvoxamine—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000278	0.00872	CbGeAlD
Fluvoxamine—SIGMAR1—lymph node—acquired immunodeficiency syndrome	0.000275	0.00864	CbGeAlD
Fluvoxamine—CYP1A2—lung—acquired immunodeficiency syndrome	0.000274	0.0086	CbGeAlD
Fluvoxamine—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000271	0.00851	CbGeAlD
Fluvoxamine—CYP1A1—lung—acquired immunodeficiency syndrome	0.00027	0.00849	CbGeAlD
Fluvoxamine—CYP3A5—lung—acquired immunodeficiency syndrome	0.000264	0.0083	CbGeAlD
Fluvoxamine—CYP2B6—lung—acquired immunodeficiency syndrome	0.000263	0.00825	CbGeAlD
Fluvoxamine—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.00025	0.00786	CbGeAlD
Fluvoxamine—CYP2E1—lung—acquired immunodeficiency syndrome	0.000246	0.00774	CbGeAlD
Fluvoxamine—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000243	0.00764	CbGeAlD
Fluvoxamine—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000241	0.00757	CbGeAlD
Fluvoxamine—ABCB1—retina—acquired immunodeficiency syndrome	0.000239	0.00752	CbGeAlD
Fluvoxamine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000237	0.00746	CbGeAlD
Fluvoxamine—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000234	0.00735	CbGeAlD
Fluvoxamine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000234	0.00734	CbGeAlD
Fluvoxamine—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000228	0.00717	CbGeAlD
Fluvoxamine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000226	0.0071	CbGeAlD
Fluvoxamine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000223	0.00699	CbGeAlD
Fluvoxamine—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.00022	0.0069	CbGeAlD
Fluvoxamine—CYP1A1—brain—acquired immunodeficiency syndrome	0.000191	0.00601	CbGeAlD
Fluvoxamine—CYP2B6—brain—acquired immunodeficiency syndrome	0.000186	0.00584	CbGeAlD
Fluvoxamine—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000185	0.00581	CbGeAlD
Fluvoxamine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000184	0.00577	CbGeAlD
Fluvoxamine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000181	0.00568	CbGeAlD
Fluvoxamine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000177	0.00555	CbGeAlD
Fluvoxamine—CYP2E1—brain—acquired immunodeficiency syndrome	0.000174	0.00548	CbGeAlD
Fluvoxamine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000174	0.00546	CbGeAlD
Fluvoxamine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.00017	0.00534	CbGeAlD
Fluvoxamine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000168	0.00528	CbGeAlD
Fluvoxamine—ABCB1—blood—acquired immunodeficiency syndrome	0.00016	0.00503	CbGeAlD
Fluvoxamine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000155	0.00487	CbGeAlD
Fluvoxamine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000154	0.00485	CbGeAlD
Fluvoxamine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000148	0.00466	CbGeAlD
Fluvoxamine—ABCB1—lung—acquired immunodeficiency syndrome	0.00014	0.00441	CbGeAlD
Fluvoxamine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000138	0.00434	CbGeAlD
Fluvoxamine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.00013	0.00408	CbGeAlD
Fluvoxamine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000125	0.00393	CbGeAlD
Fluvoxamine—ABCB1—brain—acquired immunodeficiency syndrome	9.93e-05	0.00312	CbGeAlD
Fluvoxamine—ABCB1—lymph node—acquired immunodeficiency syndrome	9.6e-05	0.00302	CbGeAlD
Fluvoxamine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	6.86e-05	0.000309	CcSEcCtD
Fluvoxamine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	6.86e-05	0.000309	CcSEcCtD
Fluvoxamine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	6.84e-05	0.000308	CcSEcCtD
Fluvoxamine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	6.84e-05	0.000308	CcSEcCtD
Fluvoxamine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	6.84e-05	0.000308	CcSEcCtD
Fluvoxamine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	6.82e-05	0.000307	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	6.79e-05	0.000306	CcSEcCtD
Fluvoxamine—Pruritus—Abacavir—acquired immunodeficiency syndrome	6.78e-05	0.000306	CcSEcCtD
Fluvoxamine—Fatigue—Indinavir—acquired immunodeficiency syndrome	6.78e-05	0.000306	CcSEcCtD
Fluvoxamine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	6.78e-05	0.000306	CcSEcCtD
Fluvoxamine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	6.78e-05	0.000306	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	6.77e-05	0.000305	CcSEcCtD
Fluvoxamine—Cough—Saquinavir—acquired immunodeficiency syndrome	6.77e-05	0.000305	CcSEcCtD
Fluvoxamine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	6.76e-05	0.000305	CcSEcCtD
Fluvoxamine—Constipation—Indinavir—acquired immunodeficiency syndrome	6.73e-05	0.000303	CcSEcCtD
Fluvoxamine—Pain—Indinavir—acquired immunodeficiency syndrome	6.73e-05	0.000303	CcSEcCtD
Fluvoxamine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	6.72e-05	0.000303	CcSEcCtD
Fluvoxamine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	6.72e-05	0.000303	CcSEcCtD
Fluvoxamine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	6.72e-05	0.000303	CcSEcCtD
Fluvoxamine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	6.71e-05	0.000303	CcSEcCtD
Fluvoxamine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	6.7e-05	0.000302	CcSEcCtD
Fluvoxamine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	6.69e-05	0.000302	CcSEcCtD
Fluvoxamine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	6.69e-05	0.000302	CcSEcCtD
Fluvoxamine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	6.68e-05	0.000301	CcSEcCtD
Fluvoxamine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	6.68e-05	0.000301	CcSEcCtD
Fluvoxamine—Malaise—Lamivudine—acquired immunodeficiency syndrome	6.67e-05	0.000301	CcSEcCtD
Fluvoxamine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	6.66e-05	0.0003	CcSEcCtD
Fluvoxamine—Nausea—Didanosine—acquired immunodeficiency syndrome	6.66e-05	0.0003	CcSEcCtD
Fluvoxamine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	6.65e-05	0.0003	CcSEcCtD
Fluvoxamine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	6.65e-05	0.0003	CcSEcCtD
Fluvoxamine—Syncope—Lamivudine—acquired immunodeficiency syndrome	6.64e-05	0.000299	CcSEcCtD
Fluvoxamine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	6.63e-05	0.000299	CcSEcCtD
Fluvoxamine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	6.63e-05	0.000299	CcSEcCtD
Fluvoxamine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	6.62e-05	0.000299	CcSEcCtD
Fluvoxamine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	6.61e-05	0.000298	CcSEcCtD
Fluvoxamine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	6.6e-05	0.000298	CcSEcCtD
Fluvoxamine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	6.6e-05	0.000298	CcSEcCtD
Fluvoxamine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	6.6e-05	0.000298	CcSEcCtD
Fluvoxamine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	6.58e-05	0.000297	CcSEcCtD
Fluvoxamine—Oedema—Ritonavir—acquired immunodeficiency syndrome	6.58e-05	0.000297	CcSEcCtD
Fluvoxamine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	6.56e-05	0.000296	CcSEcCtD
Fluvoxamine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	6.54e-05	0.000295	CcSEcCtD
Fluvoxamine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	6.53e-05	0.000294	CcSEcCtD
Fluvoxamine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	6.5e-05	0.000293	CcSEcCtD
Fluvoxamine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	6.48e-05	0.000292	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	6.48e-05	0.000292	CcSEcCtD
Fluvoxamine—Shock—Ritonavir—acquired immunodeficiency syndrome	6.47e-05	0.000292	CcSEcCtD
Fluvoxamine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	6.46e-05	0.000291	CcSEcCtD
Fluvoxamine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	6.46e-05	0.000291	CcSEcCtD
Fluvoxamine—Cough—Lamivudine—acquired immunodeficiency syndrome	6.46e-05	0.000291	CcSEcCtD
Fluvoxamine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	6.46e-05	0.000291	CcSEcCtD
Fluvoxamine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	6.45e-05	0.000291	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	6.44e-05	0.00029	CcSEcCtD
Fluvoxamine—Dizziness—Stavudine—acquired immunodeficiency syndrome	6.44e-05	0.00029	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	6.43e-05	0.00029	CcSEcCtD
Fluvoxamine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	6.43e-05	0.00029	CcSEcCtD
Fluvoxamine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	6.42e-05	0.00029	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	6.42e-05	0.000289	CcSEcCtD
Fluvoxamine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	6.41e-05	0.000289	CcSEcCtD
Fluvoxamine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	6.41e-05	0.000289	CcSEcCtD
Fluvoxamine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	6.41e-05	0.000289	CcSEcCtD
Fluvoxamine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	6.39e-05	0.000288	CcSEcCtD
Fluvoxamine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	6.38e-05	0.000288	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	6.36e-05	0.000287	CcSEcCtD
Fluvoxamine—Constipation—Efavirenz—acquired immunodeficiency syndrome	6.36e-05	0.000287	CcSEcCtD
Fluvoxamine—Pain—Efavirenz—acquired immunodeficiency syndrome	6.36e-05	0.000287	CcSEcCtD
Fluvoxamine—Rash—Nevirapine—acquired immunodeficiency syndrome	6.36e-05	0.000287	CcSEcCtD
Fluvoxamine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	6.35e-05	0.000286	CcSEcCtD
Fluvoxamine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	6.34e-05	0.000286	CcSEcCtD
Fluvoxamine—Dizziness—Abacavir—acquired immunodeficiency syndrome	6.34e-05	0.000286	CcSEcCtD
Fluvoxamine—Oedema—Saquinavir—acquired immunodeficiency syndrome	6.33e-05	0.000286	CcSEcCtD
Fluvoxamine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	6.32e-05	0.000285	CcSEcCtD
Fluvoxamine—Headache—Nevirapine—acquired immunodeficiency syndrome	6.32e-05	0.000285	CcSEcCtD
Fluvoxamine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	6.3e-05	0.000284	CcSEcCtD
Fluvoxamine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	6.3e-05	0.000284	CcSEcCtD
Fluvoxamine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	6.3e-05	0.000284	CcSEcCtD
Fluvoxamine—Infection—Saquinavir—acquired immunodeficiency syndrome	6.29e-05	0.000284	CcSEcCtD
Fluvoxamine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	6.28e-05	0.000283	CcSEcCtD
Fluvoxamine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	6.27e-05	0.000283	CcSEcCtD
Fluvoxamine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	6.26e-05	0.000282	CcSEcCtD
Fluvoxamine—Urticaria—Indinavir—acquired immunodeficiency syndrome	6.25e-05	0.000282	CcSEcCtD
Fluvoxamine—Shock—Saquinavir—acquired immunodeficiency syndrome	6.23e-05	0.000281	CcSEcCtD
Fluvoxamine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	6.23e-05	0.000281	CcSEcCtD
Fluvoxamine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	6.22e-05	0.000281	CcSEcCtD
Fluvoxamine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	6.22e-05	0.000281	CcSEcCtD
Fluvoxamine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	6.21e-05	0.00028	CcSEcCtD
Fluvoxamine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	6.21e-05	0.00028	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	6.2e-05	0.00028	CcSEcCtD
Fluvoxamine—Vomiting—Stavudine—acquired immunodeficiency syndrome	6.19e-05	0.000279	CcSEcCtD
Fluvoxamine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	6.18e-05	0.000279	CcSEcCtD
Fluvoxamine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	6.16e-05	0.000278	CcSEcCtD
Fluvoxamine—Rash—Nelfinavir—acquired immunodeficiency syndrome	6.16e-05	0.000278	CcSEcCtD
Fluvoxamine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	6.15e-05	0.000277	CcSEcCtD
Fluvoxamine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	6.15e-05	0.000277	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	6.14e-05	0.000277	CcSEcCtD
Fluvoxamine—Rash—Stavudine—acquired immunodeficiency syndrome	6.14e-05	0.000277	CcSEcCtD
Fluvoxamine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	6.13e-05	0.000277	CcSEcCtD
Fluvoxamine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	6.13e-05	0.000277	CcSEcCtD
Fluvoxamine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	6.13e-05	0.000276	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	6.12e-05	0.000276	CcSEcCtD
Fluvoxamine—Headache—Nelfinavir—acquired immunodeficiency syndrome	6.12e-05	0.000276	CcSEcCtD
Fluvoxamine—Headache—Stavudine—acquired immunodeficiency syndrome	6.1e-05	0.000275	CcSEcCtD
Fluvoxamine—Vomiting—Abacavir—acquired immunodeficiency syndrome	6.1e-05	0.000275	CcSEcCtD
Fluvoxamine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	6.09e-05	0.000275	CcSEcCtD
Fluvoxamine—Pain—Delavirdine—acquired immunodeficiency syndrome	6.08e-05	0.000274	CcSEcCtD
Fluvoxamine—Constipation—Delavirdine—acquired immunodeficiency syndrome	6.08e-05	0.000274	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	6.08e-05	0.000274	CcSEcCtD
Fluvoxamine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	6.07e-05	0.000274	CcSEcCtD
Fluvoxamine—Rash—Abacavir—acquired immunodeficiency syndrome	6.05e-05	0.000273	CcSEcCtD
Fluvoxamine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	6.04e-05	0.000272	CcSEcCtD
Fluvoxamine—Oedema—Lamivudine—acquired immunodeficiency syndrome	6.04e-05	0.000272	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	6.04e-05	0.000272	CcSEcCtD
Fluvoxamine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	6.04e-05	0.000272	CcSEcCtD
Fluvoxamine—Headache—Abacavir—acquired immunodeficiency syndrome	6.01e-05	0.000271	CcSEcCtD
Fluvoxamine—Infection—Lamivudine—acquired immunodeficiency syndrome	6e-05	0.000271	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	5.99e-05	0.00027	CcSEcCtD
Fluvoxamine—Nausea—Nevirapine—acquired immunodeficiency syndrome	5.99e-05	0.00027	CcSEcCtD
Fluvoxamine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	5.99e-05	0.00027	CcSEcCtD
Fluvoxamine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	5.95e-05	0.000268	CcSEcCtD
Fluvoxamine—Shock—Lamivudine—acquired immunodeficiency syndrome	5.94e-05	0.000268	CcSEcCtD
Fluvoxamine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	5.92e-05	0.000267	CcSEcCtD
Fluvoxamine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	5.92e-05	0.000267	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	5.91e-05	0.000267	CcSEcCtD
Fluvoxamine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	5.91e-05	0.000266	CcSEcCtD
Fluvoxamine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	5.91e-05	0.000266	CcSEcCtD
Fluvoxamine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	5.88e-05	0.000265	CcSEcCtD
Fluvoxamine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	5.88e-05	0.000265	CcSEcCtD
Fluvoxamine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	5.86e-05	0.000264	CcSEcCtD
Fluvoxamine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	5.86e-05	0.000264	CcSEcCtD
Fluvoxamine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	5.85e-05	0.000264	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	5.84e-05	0.000263	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	5.82e-05	0.000262	CcSEcCtD
Fluvoxamine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	5.8e-05	0.000262	CcSEcCtD
Fluvoxamine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	5.8e-05	0.000261	CcSEcCtD
Fluvoxamine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	5.79e-05	0.000261	CcSEcCtD
Fluvoxamine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	5.79e-05	0.000261	CcSEcCtD
Fluvoxamine—Nausea—Stavudine—acquired immunodeficiency syndrome	5.78e-05	0.000261	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	5.77e-05	0.00026	CcSEcCtD
Fluvoxamine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	5.76e-05	0.00026	CcSEcCtD
Fluvoxamine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	5.73e-05	0.000258	CcSEcCtD
Fluvoxamine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	5.72e-05	0.000258	CcSEcCtD
Fluvoxamine—Nausea—Abacavir—acquired immunodeficiency syndrome	5.7e-05	0.000257	CcSEcCtD
Fluvoxamine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	5.69e-05	0.000256	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	5.68e-05	0.000256	CcSEcCtD
Fluvoxamine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	5.67e-05	0.000256	CcSEcCtD
Fluvoxamine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	5.65e-05	0.000255	CcSEcCtD
Fluvoxamine—Asthenia—Indinavir—acquired immunodeficiency syndrome	5.65e-05	0.000255	CcSEcCtD
Fluvoxamine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	5.64e-05	0.000255	CcSEcCtD
Fluvoxamine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	5.64e-05	0.000255	CcSEcCtD
Fluvoxamine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	5.63e-05	0.000254	CcSEcCtD
Fluvoxamine—Constipation—Ritonavir—acquired immunodeficiency syndrome	5.63e-05	0.000254	CcSEcCtD
Fluvoxamine—Pain—Ritonavir—acquired immunodeficiency syndrome	5.63e-05	0.000254	CcSEcCtD
Fluvoxamine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	5.62e-05	0.000254	CcSEcCtD
Fluvoxamine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	5.62e-05	0.000254	CcSEcCtD
Fluvoxamine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	5.6e-05	0.000252	CcSEcCtD
Fluvoxamine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	5.57e-05	0.000251	CcSEcCtD
Fluvoxamine—Pruritus—Indinavir—acquired immunodeficiency syndrome	5.57e-05	0.000251	CcSEcCtD
Fluvoxamine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	5.5e-05	0.000248	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	5.5e-05	0.000248	CcSEcCtD
Fluvoxamine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	5.48e-05	0.000247	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	5.47e-05	0.000246	CcSEcCtD
Fluvoxamine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	5.46e-05	0.000246	CcSEcCtD
Fluvoxamine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	5.46e-05	0.000246	CcSEcCtD
Fluvoxamine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	5.42e-05	0.000245	CcSEcCtD
Fluvoxamine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	5.42e-05	0.000244	CcSEcCtD
Fluvoxamine—Pain—Saquinavir—acquired immunodeficiency syndrome	5.41e-05	0.000244	CcSEcCtD
Fluvoxamine—Constipation—Saquinavir—acquired immunodeficiency syndrome	5.41e-05	0.000244	CcSEcCtD
Fluvoxamine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	5.39e-05	0.000243	CcSEcCtD
Fluvoxamine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	5.38e-05	0.000243	CcSEcCtD
Fluvoxamine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	5.38e-05	0.000243	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	5.38e-05	0.000243	CcSEcCtD
Fluvoxamine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	5.37e-05	0.000242	CcSEcCtD
Fluvoxamine—Rash—Zidovudine—acquired immunodeficiency syndrome	5.33e-05	0.000241	CcSEcCtD
Fluvoxamine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	5.33e-05	0.000241	CcSEcCtD
Fluvoxamine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	5.33e-05	0.00024	CcSEcCtD
Fluvoxamine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	5.32e-05	0.00024	CcSEcCtD
Fluvoxamine—Headache—Zidovudine—acquired immunodeficiency syndrome	5.3e-05	0.000239	CcSEcCtD
Fluvoxamine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	5.26e-05	0.000237	CcSEcCtD
Fluvoxamine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	5.25e-05	0.000237	CcSEcCtD
Fluvoxamine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	5.24e-05	0.000236	CcSEcCtD
Fluvoxamine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	5.23e-05	0.000236	CcSEcCtD
Fluvoxamine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	5.22e-05	0.000235	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	5.21e-05	0.000235	CcSEcCtD
Fluvoxamine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	5.21e-05	0.000235	CcSEcCtD
Fluvoxamine—Dizziness—Indinavir—acquired immunodeficiency syndrome	5.2e-05	0.000235	CcSEcCtD
Fluvoxamine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	5.2e-05	0.000234	CcSEcCtD
Fluvoxamine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	5.2e-05	0.000234	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	5.18e-05	0.000233	CcSEcCtD
Fluvoxamine—Constipation—Lamivudine—acquired immunodeficiency syndrome	5.17e-05	0.000233	CcSEcCtD
Fluvoxamine—Pain—Lamivudine—acquired immunodeficiency syndrome	5.17e-05	0.000233	CcSEcCtD
Fluvoxamine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	5.1e-05	0.00023	CcSEcCtD
Fluvoxamine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	5.09e-05	0.000229	CcSEcCtD
Fluvoxamine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	5.03e-05	0.000227	CcSEcCtD
Fluvoxamine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	5.03e-05	0.000227	CcSEcCtD
Fluvoxamine—Nausea—Zidovudine—acquired immunodeficiency syndrome	5.03e-05	0.000227	CcSEcCtD
Fluvoxamine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	5.01e-05	0.000226	CcSEcCtD
Fluvoxamine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	5.01e-05	0.000226	CcSEcCtD
Fluvoxamine—Vomiting—Indinavir—acquired immunodeficiency syndrome	5e-05	0.000226	CcSEcCtD
Fluvoxamine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	4.98e-05	0.000224	CcSEcCtD
Fluvoxamine—Rash—Indinavir—acquired immunodeficiency syndrome	4.96e-05	0.000224	CcSEcCtD
Fluvoxamine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	4.96e-05	0.000224	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	4.94e-05	0.000223	CcSEcCtD
Fluvoxamine—Headache—Indinavir—acquired immunodeficiency syndrome	4.93e-05	0.000222	CcSEcCtD
Fluvoxamine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	4.92e-05	0.000222	CcSEcCtD
Fluvoxamine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	4.87e-05	0.000219	CcSEcCtD
Fluvoxamine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	4.85e-05	0.000219	CcSEcCtD
Fluvoxamine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	4.8e-05	0.000216	CcSEcCtD
Fluvoxamine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	4.77e-05	0.000215	CcSEcCtD
Fluvoxamine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	4.77e-05	0.000215	CcSEcCtD
Fluvoxamine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	4.73e-05	0.000213	CcSEcCtD
Fluvoxamine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	4.72e-05	0.000213	CcSEcCtD
Fluvoxamine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	4.7e-05	0.000212	CcSEcCtD
Fluvoxamine—Rash—Efavirenz—acquired immunodeficiency syndrome	4.69e-05	0.000211	CcSEcCtD
Fluvoxamine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	4.68e-05	0.000211	CcSEcCtD
Fluvoxamine—Nausea—Indinavir—acquired immunodeficiency syndrome	4.67e-05	0.000211	CcSEcCtD
Fluvoxamine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	4.66e-05	0.00021	CcSEcCtD
Fluvoxamine—Headache—Efavirenz—acquired immunodeficiency syndrome	4.66e-05	0.00021	CcSEcCtD
Fluvoxamine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	4.65e-05	0.00021	CcSEcCtD
Fluvoxamine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	4.54e-05	0.000205	CcSEcCtD
Fluvoxamine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	4.52e-05	0.000204	CcSEcCtD
Fluvoxamine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	4.5e-05	0.000203	CcSEcCtD
Fluvoxamine—Rash—Delavirdine—acquired immunodeficiency syndrome	4.49e-05	0.000202	CcSEcCtD
Fluvoxamine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	4.48e-05	0.000202	CcSEcCtD
Fluvoxamine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	4.48e-05	0.000202	CcSEcCtD
Fluvoxamine—Headache—Delavirdine—acquired immunodeficiency syndrome	4.46e-05	0.000201	CcSEcCtD
Fluvoxamine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	4.45e-05	0.000201	CcSEcCtD
Fluvoxamine—Nausea—Efavirenz—acquired immunodeficiency syndrome	4.42e-05	0.000199	CcSEcCtD
Fluvoxamine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	4.35e-05	0.000196	CcSEcCtD
Fluvoxamine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	4.33e-05	0.000195	CcSEcCtD
Fluvoxamine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	4.33e-05	0.000195	CcSEcCtD
Fluvoxamine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	4.27e-05	0.000193	CcSEcCtD
Fluvoxamine—Nausea—Delavirdine—acquired immunodeficiency syndrome	4.23e-05	0.000191	CcSEcCtD
Fluvoxamine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	4.19e-05	0.000189	CcSEcCtD
Fluvoxamine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	4.18e-05	0.000189	CcSEcCtD
Fluvoxamine—Rash—Ritonavir—acquired immunodeficiency syndrome	4.15e-05	0.000187	CcSEcCtD
Fluvoxamine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	4.14e-05	0.000187	CcSEcCtD
Fluvoxamine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	4.13e-05	0.000186	CcSEcCtD
Fluvoxamine—Headache—Ritonavir—acquired immunodeficiency syndrome	4.12e-05	0.000186	CcSEcCtD
Fluvoxamine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	4.03e-05	0.000182	CcSEcCtD
Fluvoxamine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	3.99e-05	0.00018	CcSEcCtD
Fluvoxamine—Rash—Saquinavir—acquired immunodeficiency syndrome	3.99e-05	0.00018	CcSEcCtD
Fluvoxamine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	3.99e-05	0.00018	CcSEcCtD
Fluvoxamine—Headache—Saquinavir—acquired immunodeficiency syndrome	3.97e-05	0.000179	CcSEcCtD
Fluvoxamine—Nausea—Ritonavir—acquired immunodeficiency syndrome	3.91e-05	0.000176	CcSEcCtD
Fluvoxamine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	3.84e-05	0.000173	CcSEcCtD
Fluvoxamine—Rash—Lamivudine—acquired immunodeficiency syndrome	3.81e-05	0.000172	CcSEcCtD
Fluvoxamine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	3.8e-05	0.000172	CcSEcCtD
Fluvoxamine—Headache—Lamivudine—acquired immunodeficiency syndrome	3.78e-05	0.000171	CcSEcCtD
Fluvoxamine—Nausea—Saquinavir—acquired immunodeficiency syndrome	3.76e-05	0.00017	CcSEcCtD
Fluvoxamine—Nausea—Lamivudine—acquired immunodeficiency syndrome	3.59e-05	0.000162	CcSEcCtD
